Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Choudhary

Showing results (101-110 of 453) with videos related to

Pageof 46
Sort By:
Annals of Internal Medicine|April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases|September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody TherapyRinki Deo, Manish C Choudhary, Owen T Glover, et al.
JAMA Network Open|September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral TreatmentTrevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|November 6, 2023
COVID-19-Associated Portal Vein Thrombosis Post-CholecystitisSara Guevara, Santiago J Miyara, Judith Aronsohn, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Nature Microbiology|October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trialManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Plos Pathogens|May 12, 2026
Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failureMelendhran Pillay, Manish C Choudhary, Rinki Deo, et al.
Research Square|December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Pageof 46

Showing results (101-110 of 453) with videos related to

Sort By:
Pageof 46
Annals of Internal Medicine|April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases|September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody TherapyRinki Deo, Manish C Choudhary, Owen T Glover, et al.
JAMA Network Open|September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral TreatmentTrevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|November 6, 2023
COVID-19-Associated Portal Vein Thrombosis Post-CholecystitisSara Guevara, Santiago J Miyara, Judith Aronsohn, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Nature Microbiology|October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trialManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Plos Pathogens|May 12, 2026
Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failureMelendhran Pillay, Manish C Choudhary, Rinki Deo, et al.
Research Square|December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Pageof 46